Results 101 to 110 of about 3,371,463 (244)

Technology considerations in health professions and clinical education [PDF]

, 2020
A Stirling, A Winkelmann, AA Ali, B Klímová, BM Kuehn, Bohong Cai, C Dong, C Girard, C Hanson, C Liu, C Moro, C Moro, C Moro, C Moro, C Moro, C Moro, C Nelson, C Pimmer, CA Kilmon, CC Cheston, CE Jenson, DA Cook, DA Cook, DA Cook, DB Jones, E Atlantis, EA Boyle, F Hosseini, F Ricciardi, G Ramsey-Stewart, G Wong, H Maertens, H Owen, HH Malik, I Duncan, I Gorbanev, I Sural, J Abraham, J Birt, J Birt, J Sutherland, JA Delello, JF Knight, JH Kim, KHA Lim, L Briz-Ponce, LM Miller, M Anand, M Sterling, N Jayakumar, NJ Hunsu, OJ Petit DIT Dariel, P Lall, P Robert, PP George, R Chugh, R Wang, S Gough, S Gough, S Gough, S Mccallum, S O’connor, S O’connor, SA Adams, SA Azer, SA Moorhead, SV Gentry, T Custer, V Mathiowetz, W Jin, W Su, W Tuong, WC Mcgaghie, WC Mcgaghie   +73 more
core   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source

Targeting TNBC: core–shell polycationic polyurea dendrimers with inherent anticancer activity

FEBS Open Bio, EarlyView.
Core–shell polycationic PURE dendrimers were tested in TNBC‐derived tumor models. Both formulations selectively targeted TNBC and effectively reduced tumor volume. PUREG4‐OEI48 suppressed tumor growth without detectable toxicity, whereas PUREG4‐OCEI24, despite showing efficacy, induced hepatic toxicity.
Adriana Cruz, Bruna Abreu, Cindy Mendes, Catarina Freitas‐Dias, Filipe Gonçalves, Fernanda Silva, José Ramalho, Saudade André, Vasco D. B. Bonifácio, Jacinta Serpa   +9 more
wiley   +1 more source

Establishment of a coculture system for Porphyromonas gingivalis and head and neck squamous cell carcinoma using spheroid culture and LATS inhibition

FEBS Open Bio, EarlyView.
We established a spheroid coculture system enabling viable Porphyromonas gingivalis–HNSCC interactions under normoxic conditions. Inhibition of LATS1/2 maintains tumor cells in an undifferentiated state, which may promote spheroid growth and create a more permissive environment for bacterial persistence.
Yurika Nakajima, Shogo Okazaki, Muneaki Tamura, Shuichi Sato, Kenichi Imai   +4 more
wiley   +1 more source

CEC: Clinical Exchange Corner [PDF]

, 2010
Clinical Education Complex, WKU, Reynolds, Laura   +1 more
core   +1 more source

How to … Maximise Your Clinical Education Research Impact. [PDF]

Clin Teach
Sims DA, Sandars J, Wong WYA, Samuriwo R, Burford B.   +4 more
europepmc   +1 more source

Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK/STAT1 signaling pathway

FEBS Open Bio, EarlyView.
We found that during chemotherapy‐induced alopecia (CIA), Sonic hedgehog (Shh) expression significantly decreased in hair follicle Shh+ cells, whereas the Janus‐activated kinase/signal transducer and activator of transcription 1 (JAK/STAT1) signaling pathway was markedly activated.
Ruifang Fan, Jingling Huang, Xiang Lin, Tingjiao Lan, Yuli Tang, Ling Sun, Guixuan Zhou   +6 more
wiley   +1 more source

How to … Apply for a Research Fellowship in Clinical Education: The 'Six Ps' of Success. [PDF]

Clin Teach
Tiffin PA, Wardle K, Kasadha B, Vance G, Medisauskaite A, Kelley E, Henry C, Park S, Thompson P, Woolf K.   +9 more
europepmc   +1 more source